KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Debt (2016 - 2026)

AbbVie has reported Total Debt over the past 14 years, most recently at $61.4 billion for Q4 2025.

  • Quarterly Total Debt fell 8.5% to $61.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.4 billion through Dec 2025, down 8.5% year-over-year, with the annual reading at $61.4 billion for FY2025, 8.5% down from the prior year.
  • Total Debt was $61.4 billion for Q4 2025 at AbbVie, down from $65.0 billion in the prior quarter.
  • Over five years, Total Debt peaked at $85.5 billion in Q1 2021 and troughed at $55.8 billion in Q2 2023.
  • The 5-year median for Total Debt is $65.5 billion (2025), against an average of $67.0 billion.
  • The largest YoY upside for Total Debt was 35.13% in 2021 against a maximum downside of 25.36% in 2021.
  • A 5-year view of Total Debt shows it stood at $64.2 billion in 2021, then decreased by 1.45% to $63.3 billion in 2022, then dropped by 6.14% to $59.4 billion in 2023, then grew by 13.07% to $67.1 billion in 2024, then decreased by 8.5% to $61.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Total Debt are $61.4 billion (Q4 2025), $65.0 billion (Q3 2025), and $65.0 billion (Q2 2025).